Ovid Therapeutics Inc. (OVID)

Ovid Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	55	228	131	219	147	198
Market Cap Growth	18.58%	73.64%	-40.04%	49.16%	-26.16%	232.60%
Enterprise Value	8	166	17	29	75	122
PE Ratio	-	-4.35	-2.42	1.78	-1.81	-3.28
PS Ratio	115.87	581.04	87.22	1.05	11.61	-
PB Ratio	0.70	2.59	0.99	1.22	3.36	2.83
P/FCF Ratio	-4.28	-4.97	-2.32	1.85	-2.83	-3.88
P/OCF Ratio	-4.28	-4.97	-2.37	1.84	-2.84	-3.88
EV/Sales Ratio	17.69	423.36	11.09	0.14	5.90	-
EV/EBITDA Ratio	-3.45	-3.27	-0.32	0.23	-0.92	-2.02
EV/EBIT Ratio	-3.34	-3.17	-0.31	0.23	-0.92	-2.01
EV/FCF Ratio	-3.36	-3.62	-0.30	0.24	-1.44	-2.38
Debt / Equity Ratio	0.58	0.52	0.13	-	-	-
Debt / EBITDA Ratio	-0.93	-0.91	-0.31	-	-	-
Debt / FCF Ratio	-0.91	-1.00	-0.29	-	-	-
Quick Ratio	10.35	9.39	18.73	12.82	3.27	7.39
Current Ratio	10.47	9.55	18.79	12.87	3.39	7.58
Asset Turnover	0.00	0.00	0.01	0.97	0.18	0
Return on Equity (ROE)	-53.60%	-49.80%	-36.60%	61.10%	-171.30%	-119.30%
Return on Assets (ROA)	-37.80%	-38.20%	-31.50%	57.30%	-118.00%	-99.50%
Return on Capital (ROIC)	-49.85%	-44.31%	-37.33%	68.36%	-186.63%	-87.70%
Earnings Yield	-92.36%	-23.00%	-41.33%	56.20%	-55.30%	-30.47%
FCF Yield	-91.86%	-20.13%	-43.07%	54.18%	-35.29%	-25.78%
Buyback Yield / Dilution	-0.32%	-0.22%	-3.46%	-16.45%	-49.04%	-59.22%
Total Shareholder Return	-0.32%	-0.22%	-3.46%	-16.45%	-49.04%	-59.22%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).